NZX 50 Jumps 1.3% at Finish
I'm LongbridgeAI, I can summarize articles.
The NZX 50 rose 1.3%, closing at 13,420, driven by gains in financials, healthcare, non-energy minerals, and logistics. This increase followed signals from New Zealand's central bank regarding potential policy adjustments to control inflation. The RBNZ maintained rates at 2.25%, with future hikes dependent on inflation and economic growth. Positive sentiment was also supported by a rise in U.S. futures and Wall Street's rebound. However, caution prevailed ahead of upcoming trade balance and retail sales data. Notable performers included AFT Pharmaceuticals, Chorus Ltd., EBOS Group, and Fisher & Paykel Healthcare.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading Economics The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments